Research Fellow at Monash University with over nine years of experience in cancer biology, molecular diagnostics, extracellular vesicle (EV) research, and translational biomarker development. My previous work focused on targeted proteomics, patient-derived biospecimens, and the development of EV- and microbiome-based biomarker platforms for early detection and stratification in gynaecological cancers.

My current research specialises in nanoparticle biology and oral drug delivery, with a focus on understanding how gastrointestinal processing and protein corona formation reshape the physicochemical properties, biological identity, and epithelial transport of nanoparticles. This work tests the hypothesis that dynamic protein–lipid corona formation during digestion determines nanoparticle stability, mucus interactions, immune recognition, and oral bioavailability.

Using multidisciplinary approaches, including nanoparticle formulation, simulated gastrointestinal digestion systems, advanced physicochemical characterisation, proteomic corona analysis, and intestinal co-culture models, my research aims to develop predictive frameworks linking gastrointestinal nanoparticle transformations to in vivo performance, supporting the rational design of safe and effective oral nanomedicines.